Oncolytics Biotech (ONCY) Change in Acquisitions & Divestments (2009 - 2023)

Oncolytics Biotech's (ONCY) quarterly Change in Acquisitions & Divestments came in at $5.0 million in Q3 2023, little changed on a QoQ basis from $5.1 million in Q2 2023.

Oncolytics Biotech (ONCY) Change in Acquisitions & Divestments (2009 - 2023) Analysis & Trends

Oncolytics Biotech (ONCY) has 10 years of Change in Acquisitions & Divestments data on file, last reported at $5.0 million in Q3 2023.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $5.0 million in Q3 2023; TTM through Dec 2023 was $15.0 million, a N/A change from a year earlier, with the FY2023 full-year figure at $15.0 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments for Q3 2023 stood at $5.0 million, roughly flat from $5.1 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for ONCY reached as high as $5.1 million in Q2 2023 and fell as low as $4.9 million in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,019.86 Bn 66,019.58 Bn -
2 Nanobiotix 1,909.20 Bn 1,909.14 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 468.20 Bn 463.41 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.50 Bn 115.26 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.15 Bn 61.39 Bn 3.31 Bn
7 Belite Bio 62.66 Bn 62.66 Bn -
8 Argenx Se 55.58 Bn 50.39 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.43 Bn 34.43 Bn 959.66 Mn
10 Oncolytics Biotech 76.41 Mn 76.41 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 5.05 Mn
Sep 30, 2023 5.05 Mn
Jun 30, 2023 5.05 Mn
Jun 30, 2023 5.05 Mn
Mar 31, 2023 4.94 Mn
Mar 31, 2023 4.94 Mn
Mar 31, 2017 2.09 Mn
Mar 31, 2017 2.09 Mn
Mar 31, 2016 -27,823.00
Mar 31, 2016 -27,823.00
Mar 31, 2015 29,292.00
Mar 31, 2015 29,292.00
Dec 31, 2014 -30,041.00
Dec 31, 2014 -30,041.00
Jun 30, 2014 -60,082.00
Jun 30, 2014 -60,082.00
Mar 31, 2014 30,041.00
Mar 31, 2014 30,041.00
Mar 31, 2013 32,416.00
Mar 31, 2013 32,416.00